Dow Jones

44,546.08

-0.37%

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Conduit Pharmaceuticals Inc (CDTTW)
Conduit Pharmaceuticals Inc (CDTTW) Noticias

CDTTW

Conduit Pharmaceuticals (CDTTW)

Conduit Pharmaceuticals Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CDTTW

1

Fecha	Hora	Fuente	Título	Símbolo	Compañía
14/02/2025	16:11	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:CDTTW	Conduit Pharmaceuticals Inc
12/02/2025	23:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:CDTTW	Conduit Pharmaceuticals Inc
11/02/2025	07:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CDTTW	Conduit Pharmaceuticals Inc
10/02/2025	15:30	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:CDTTW	Conduit Pharmaceuticals Inc
06/02/2025	16:19	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:CDTTW	Conduit Pharmaceuticals Inc
05/02/2025	16:30	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:CDTTW	Conduit Pharmaceuticals Inc
21/01/2025	16:00	Edgar (US Regulatory)	Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:CDTTW	Conduit Pharmaceuticals Inc
20/12/2024	16:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CDTTW	Conduit Pharmaceuticals Inc
20/12/2024	16:05	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:CDTTW	Conduit Pharmaceuticals Inc
09/12/2024	07:30	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:CDTTW	Conduit Pharmaceuticals Inc
26/11/2024	16:21	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:CDTTW	Conduit Pharmaceuticals Inc
14/11/2024	16:27	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CDTTW	Conduit Pharmaceuticals Inc
14/11/2024	16:24	Edgar (US Regulatory)	Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]	NASDAQ:CDTTW	Conduit Pharmaceuticals Inc
06/11/2024	05:01	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:CDTTW	Conduit Pharmaceuticals Inc
01/11/2024	16:10	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:CDTTW	Conduit Pharmaceuticals Inc
28/10/2024	16:17	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:CDTTW	Conduit Pharmaceuticals Inc
29/05/2024	15:21	GlobeNewswire Inc.	A Presidio Property Trust Major Investment To Be Part of Russell 2000®	NASDAQ:CDTTW	Conduit Pharmaceuticals Inc
06/10/2023	07:30	GlobeNewswire Inc.	Presidio Property Trust Announces Closing of Merger of Its Sponsored SPAC Murphy Canyon Acquisition Corp Now Trading as Conduit Pharmaceuticals (Nasdaq: CDT and CDTTW)	NASDAQ:CDTTW	Conduit Pharmaceuticals Inc